Alzheon

Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
Clinical Trials Arena
Fri, 01/10/25 - 11:18 am
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Alzheon
Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing
Genetic Engineering News
Wed, 06/12/24 - 11:29 pm
Alzheon
clinical trials
funding
Alzheimer's disease
valiltramiprosate
Alzheimer's biotech Alzheon nets $50M Series D
Endpoints
Thu, 04/14/22 - 10:53 am
Alzheon
funding
Alzheimer's disease
ALZ-801
'Very over sold': Biotech brags about PhII Alzheimer's data, but experts are underwhelmed
Endpoints
Wed, 02/9/22 - 10:11 am
Alzheon
Alzheimer's disease
ALZ-801
clinical trials
New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought
BioSpace
Tue, 03/9/21 - 09:53 pm
Alzheon
Alzheimer's disease
ALZ-801
Alzheon returns, with a $47 million NIH grant and one last shot at a pivotal PhIII Alzheimer’s success
Endpoints
Thu, 08/20/20 - 10:43 am
Alzheon
NIH
grants
Alzheimer's disease
ALZ-801
Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt
Endpoints
Thu, 01/17/19 - 09:42 am
Alzheon
IPOs
clinical trials
ALZ-801
Alzheimer's disease
Second time lucky? Alzheon tries for much-reduced IPO
Fierce Biotech
Tue, 08/28/18 - 10:33 am
Alzheon
IPOs
Alzheimer's disease
tramiprosate
Alzheon steps back from an IPO, further than ever from a PhIII Alzheimer’s study
Endpoints
Sat, 04/28/18 - 11:47 am
Alzheon
Alzheimer's disease
clinical trials
ALZ-801
IPOs
Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug
Xconomy
Sun, 03/18/18 - 11:30 am
Alzheon
Alzheimer's disease
IPOs
ALZ-801
New data from Alzheon shows long-term benefit for Alzheimer's
BioPharma Dive
Tue, 07/18/17 - 11:33 am
Alzheon
Alzheimer's disease
ALZ-801
Alzheon says data backs potential of Alzheimer's candidate
PM Live
Fri, 06/23/17 - 03:34 pm
Alzheon
Alzheimer's disease
tramiprosate
A Little Known Drug Company Could Have The Answer For Some Alzheimer's Patients
Forbes
Fri, 10/7/16 - 09:04 am
Alzheimer's disease
Alzheon
ALK-801
Little Alzheon looks to raise $100M for a “derisked” Alzheimer’s PhIII
Endpoints
Mon, 07/25/16 - 10:54 am
Alzheon
Alzheimer's disease
ALZ-801
A small biotech in a daunting field, Alzheon begins new Alzheimer’s study
Bizjournals.com
Fri, 11/6/15 - 10:40 am
Alzheon
Alzheimer's disease
ALZ-801
Alzheon CEO calls out Biogen, says his firm will be 1st to Alzheimer's finish line
BioPharma Dive
Fri, 04/10/15 - 03:48 pm
Alzheimer's disease
Alzheon
Biogen
Alzheon's CEO says he can beat Biogen with the world’s first Alzheimer’s drug
Bizjournals.com
Wed, 04/8/15 - 10:39 am
Alzheimer's disease
Alzheon
Biogen